Literature DB >> 24019305

Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.

Judith M Sonder1, Jessica Burggraaff, Dirk L Knol, Chris H Polman, Bernard M J Uitdehaag.   

Abstract

BACKGROUND AND OBJECTIVES: The Symbol Digit Modalities Test (SDMT) shows advantages over the Paced Auditory Serial Addition Test (PASAT) as a cognitive test in patients with multiple sclerosis (MS). To determine which of these tests is most valid and reliable over time as an indicator of the cognitive state of MS patients, long-term test results of both tests were compared in relation to scores of the Brief Repeatable Battery of Neuropsychological tests (BRBN).
METHODS: For 485 MS patients visiting the VU University Medical Center Amsterdam for different research projects, a total number of 1078 visits with BRBN (including PASAT and SDMT) was planned. Observed and model-based correlations were used to calculate the construct validity of the SDMT and PASAT 3 seconds test (PASAT3) by comparing correlations with the BRBN-sumscore. The test-retest reliability of each test was also computed.
RESULTS: For the construct validity, higher correlations were found between SDMT and BRBN compared to PASAT3 and BRBN, especially for the model-based correlations at baseline. The reliability of the measurements was good for all instruments, with the highest coefficients for the SDMT.
CONCLUSION: As a single assessment tool for cognition in MS, the SDMT is more valid and reliable compared to PASAT3.

Entities:  

Keywords:  BRBN; MSFC; Multiple sclerosis; PASAT; SDMT; cognition

Mesh:

Year:  2013        PMID: 24019305     DOI: 10.1177/1352458513501570

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  24 in total

1.  Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?

Authors:  Jessica Burggraaff; Dirk L Knol; Bernard M J Uitdehaag
Journal:  Eur Neurol       Date:  2017-03-21       Impact factor: 1.710

2.  Differentiation of Cognitive Deficit Profiles in Multiple Sclerosis Patients: Latent Profile Analysis.

Authors:  Sanela Slavković; Milica Lazić; Cynthia Honan; Čongor Nađ; Nina Brkić-Jovanović; Špela Golubović
Journal:  Med Princ Pract       Date:  2019-03-04       Impact factor: 1.927

3.  Detection of subtle gait disturbance and future fall risk in early multiple sclerosis.

Authors:  Rachel Brandstadter; Oluwasheyi Ayeni; Stephen C Krieger; Noam Y Harel; Miguel X Escalon; Ilana Katz Sand; Victoria M Leavitt; Michelle T Fabian; Korhan Buyukturkoglu; Sylvia Klineova; Claire S Riley; Fred D Lublin; Aaron E Miller; James F Sumowski
Journal:  Neurology       Date:  2020-02-26       Impact factor: 9.910

Review 4.  Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.

Authors:  Carmen Tur; Marcello Moccia; Frederik Barkhof; Jeremy Chataway; Jaume Sastre-Garriga; Alan J Thompson; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2018-01-12       Impact factor: 42.937

5.  The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients.

Authors:  Ornella Argento; Chiara C Incerti; Maria E Quartuccio; Giuseppe Magistrale; Ada Francia; Carlo Caltagirone; Valerio Pisani; Ugo Nocentini
Journal:  Neurol Sci       Date:  2018-04-27       Impact factor: 3.307

Review 6.  Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.

Authors:  Daniel Ontaneda; Robert J Fox; Jeremy Chataway
Journal:  Lancet Neurol       Date:  2015-02       Impact factor: 44.182

7.  Reliability and Validity of a Danish Version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.

Authors:  Tobias Sejbæk; Morten Blaabjerg; Pippi Sprogøe; Mads Ravnborg
Journal:  Int J MS Care       Date:  2018 Jan-Feb

8.  A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.

Authors:  Mariana López-Góngora; Luis Querol; Antonio Escartín
Journal:  BMC Neurol       Date:  2015-03-22       Impact factor: 2.474

9.  Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.

Authors:  Marisa Loitfelder; Franz Fazekas; Karl Koschutnig; Siegrid Fuchs; Katja Petrovic; Stefan Ropele; Alexander Pichler; Margit Jehna; Christian Langkammer; Reinhold Schmidt; Christa Neuper; Christian Enzinger
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

10.  Toward Digital Self-monitoring of Multiple Sclerosis: Investigating First Experiences, Needs, and Wishes of People with MS.

Authors:  Karine Wendrich; Pim van Oirschot; Marijn Bart Martens; Marco Heerings; Peter Joseph Jongen; Lotte Krabbenborg
Journal:  Int J MS Care       Date:  2019 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.